1
|
Greenhough S, Medine CN and Hay DC:
Pluripotent stem cell derived hepatocyte like cells and their
potential in toxicity screening. Toxicology. 278:250–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Okura H, Komoda H, Saga A, et al:
Properties of hepatocyte-like cell clusters from human adipose
tissue-derived mesenchymal stem cells. Tissue Engineering Part C
Methods. 16:761–770. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hamazaki T, Iiboshi Y, Oka M, et al:
Hepatic maturation in differentiating embryonic stem cells in
vitro. FEBS Lett. 497:15–19. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Touboul T, Hannan NR, Corbineau S, et al:
Generation of functional hepatocytes from human embryonic stem
cells under chemically defined conditions that recapitulate liver
development. Hepatology. 51:1754–1765. 2010. View Article : Google Scholar
|
5
|
Rambhatla L, Chiu C-P, Kundu P, Peng Y and
Carpenter MK: Generation of hepatocyte-like cells from human
embryonic stem cells. Cell Transplant. 12:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Abelev GI, Perova SD, Khramkova NI,
Postnikova ZA and Irlin IS: Production of embryonal alpha-globulin
by transplantable mouse hepatomas. Transplantation. 1:174–180.
1963. View Article : Google Scholar : PubMed/NCBI
|
7
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar
|
8
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Schievenbusch S, Schrammel T, Goeser T and
Nierhoff D: Neighbor of Punc E11 in the Mdr2-/- mouse
model: Novel marker of stem/progenitor cells in regenerating adult
liver. Hepatology. Wiley-Blackwell; MA: pp. 962A. 2011
|
10
|
Schievenbusch S, Sauer E, Curth HM, et al:
Neighbor of Punc E 11: expression pattern of the new hepatic
stem/progenitor cell marker during murine liver development. Stem
Cells. 21:2656–2666. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Salbaum JM and Kappen C: Cloning and
expression of nope, a new mouse gene of the immunoglobulin
superfamily related to guidance receptors. Genomics. 64:15–23.
2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Marquardt JU, Quasdorff M, Varnholt H, et
al: Neighbor of Punc E11, a novel oncofetal marker for
hepatocellular carcinoma. Int J Cancer. 128:2353–2363. 2011.
View Article : Google Scholar : PubMed/NCBI
|
13
|
He G, Dhar D, Nakagawa H, et al:
Identification of liver cancer progenitors whose malignant
progression depends on autocrine IL-6 signaling. Cell. 155:384–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sato Y, Nakata K, Kato Y, et al: Early
recognition of hepatocellular carcinoma based on altered profiles
of alpha-fetoprotein. N Engl J Med. 328:1802–1806. 1993. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sell S and Dunsford H: Evidence for the
stem cell origin of hepatocellular carcinoma and
cholangiocarcinoma. Am J Pathol. 134:13471989.PubMed/NCBI
|
16
|
Gebo KA, Chander G, Jenckes MW, et al:
Screening tests for hepatocellular carcinoma in patients with
chronic hepatitis C: a systematic review. Hepatology. 36:S84–S92.
2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Gupta S, Bent S and Kohlwes J: Test
characteristics of α-fetoprotein for detecting hepatocellular
carcinoma in patients with hepatitis C: A systematic review and
critical analysis. Ann Intern Med. 139:46–50. 2003.
|
18
|
Marrero JA and Feng Z: Alpha-fetoprotein
in early hepatocellular carcinoma. Gastroenterology. 138:400–401.
2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Forner A, Reig M and Bruix J:
α-fetoprotein for hepatocellular carcinoma diagnosis: the demise of
a brilliant star. Gastroenterology. 137:26–29. 2009.
|
20
|
Marrero JA, Feng Z, Wang Y, et al:
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound
alpha-fetoprotein in early hepatocellular carcinoma.
Gastroenterology. 137:110–118. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Kubota H and Reid LM: Clonogenic
hepatoblasts, common precursors for hepatocytic and biliary
lineages, are lacking classical major histocompatibility complex
class I antigen. Proc Natl Acad Sci USA. 97:12132–12137. 2000.
View Article : Google Scholar
|
22
|
Suzuki A, Zheng YW, Kondo R, et al:
Flow-cytometric separation and enrichment of hepatic progenitor
cells in the developing mouse liver. Hepatology. 32:1230–1239.
2000. View Article : Google Scholar : PubMed/NCBI
|
23
|
Watanabe T, Nakagawa K, Ohata S, et al:
SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic
hepatoblast proliferation via a pathway different from
NF-kappaB-induced anti-apoptosis. Dev Biol. 250:332–347. 2002.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Tanimizu N, Nishikawa M, Saito H,
Tsujimura T and Miyajima A: Isolation of hepatoblasts based on the
expression of Dlk/Pref-1. J Cell Sci. 116:1775–1786. 2003.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Nierhoff D, Ogawa A, Oertel M, Chen YQ and
Shafritz DA: Purification and characterization of mouse fetal liver
epithelial cells with high in vivo repopulation capacity.
Hepatology. 42:130–139. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Nitou M, Sugiyama Y, Ishikawa K and
Shiojiri N: Purification of fetal mouse hepatoblasts by magnetic
beads coated with monoclonal anti-e-cadherin antibodies and their
in vitro culture. Exp Cell Res. 279:330–343. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Rabes H: Development and growth of early
preneoplastic lesions induced in the liver by chemical carcinogens.
J Cancer Res Clin Oncol. 106:85–92. 1983. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kang JS, Kang HG, Park YI, et al:
Expression of epithelial cell adhesion molecule and proliferating
cell nuclear antigen in diethylnitrosamine induced
hepatocarcinogenesis in mice. Exp Ther Med. 5:138–142.
2013.PubMed/NCBI
|
29
|
Kang JS: Expression of epithelial cell
adhesion molecule in early phase of hepatocarcinogenesis of mice
treated with diethylnitrosamine. J Biomed Res. 13:243–247.
2012.
|
30
|
Fausto N and Campbell JS: Mouse models of
hepatocellular carcinoma. Seminars in Liver Disease. Thieme Medical
Publishers; pp. 087–098. 2010, View Article : Google Scholar
|
31
|
Kang JS, Wanibuchi H, Morimura K, Gonzalez
FJ and Fukushima S: Role of CYP2E1 in diethylnitrosamine-induced
hepatocarcinogenesis in vivo. Cancer Res. 67:11141–11146. 2007.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Bannasch P: Sequential cellular changes
during chemical carcinogenesis. J Cancer Res Clin Oncol. 108:11–22.
1984. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhang BH, Yang BH and Tang ZY: Randomized
controlled trial of screening for hepatocellular carcinoma. J
Cancer Res Clin Oncol. 130:417–422. 2004. View Article : Google Scholar : PubMed/NCBI
|
34
|
Song BC, Chung YH, Kim JA, et al:
Transforming growth factor-β1 as a useful serologic marker of small
hepatocellular carcinoma. Cancer. 94:175–180. 2002.
|
35
|
Li D, Mallory T and Satomura S: AFP-L3: a
new generation of tumor marker for hepatocellular carcinoma. Clin
Chim Acta. 313:15–19. 2001. View Article : Google Scholar : PubMed/NCBI
|
36
|
Marrero JA, Su GL, Wei W, et al: Des-gamma
carboxyprothrombin can differentiate hepatocellular carcinoma from
nonmalignant chronic liver disease in American patients.
Hepatology. 37:1114–1121. 2003. View Article : Google Scholar : PubMed/NCBI
|
37
|
Capurro M, Wanless IR, Sherman M, et al:
Glypican-3: a novel serum and histochemical marker for
hepatocellular carcinoma. Gastroenterology. 125:89–97. 2003.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Marrero JA, Romano PR, Nikolaeva O, et al:
GP73, a resident Golgi glycoprotein, is a novel serum marker for
hepatocellular carcinoma. J Hepatol. 43:1007–1012. 2005. View Article : Google Scholar : PubMed/NCBI
|
39
|
Morford LA, Davis C, Jin L, Dobierzewska
A, Peterson ML and Spear BT: The oncofetal gene glypican 3 is
regulated in the postnatal liver by zinc fingers and homeoboxes 2
and in the regenerating liver by alpha-fetoprotein regulator 2.
Hepatology. 46:1541–1547. 2007. View Article : Google Scholar : PubMed/NCBI
|